相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling
David A. Hume et al.
BLOOD (2012)
Downregulation of CD40 signal and induction of TGF-ß by phosphatidylinositol mediates reduction in immunogenicity against recombinant human Factor VIII
Puneet Gaitonde et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Impact of polymorphisms in genes involved in autoimmune disease on inhibitor development in Chinese patients with haemophilia A
Yeling Lu et al.
THROMBOSIS AND HAEMOSTASIS (2012)
The interaction of IQGAPs with calmodulin-like proteins
Sevvel Pathmanathan et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2011)
TNF-stimulated MAP kinase activation mediated by a Rho family GTPase signaling pathway
Shashi Kant et al.
GENES & DEVELOPMENT (2011)
A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A
J. N. Lozier et al.
HAEMOPHILIA (2011)
Factor XIII: novel structural and functional aspects
I. Komaromi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
IQGAP1 and IQGAP2 are Reciprocally Altered in Hepatocellular Carcinoma
Colin D. White et al.
BMC GASTROENTEROLOGY (2010)
New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development
K. Kurnik et al.
HAEMOPHILIA (2010)
Postmarketing surveillance study of KOGENATE (R) Bayer with Bio-Set (R) in patients with haemophilia A: evaluation of patients' satisfaction after switch to the new reconstitution system
N. Vidovic et al.
HAEMOPHILIA (2010)
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report
J. Astermark et al.
HAEMOPHILIA (2010)
Analysis of cytokine genes polymorphism as markers for inhibitor development in haemophilia A
D. Chaves et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2010)
Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation
Kazuhito Gotoh et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Identification of gp96 as a Novel Target for Treatment of Autoimmune Disease in Mice
Jung Min Han et al.
PLOS ONE (2010)
DOCK2 Is a Microglial Specific Regulator of Central Nervous System Innate Immunity Found in Normal and Alzheimer's Disease Brain
Patrick J. Cimino et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Conserved domains of the class A scavenger receptors: evolution and function
Dawn M. E. Bowdish et al.
IMMUNOLOGICAL REVIEWS (2009)
Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-α and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A
A. Pavlova et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Role of platelet-derived growth factors in physiology and medicine
Johanna Andrae et al.
GENES & DEVELOPMENT (2008)
A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms
Xiaoyi Gao et al.
GENETIC EPIDEMIOLOGY (2008)
Practical aspects of imputation-driven meta-analysis of genome-wide association studies
Paul I. W. de Bakker et al.
HUMAN MOLECULAR GENETICS (2008)
What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseases
Jilly F. Evans et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells
Irina Fernandez et al.
JOURNAL OF IMMUNOLOGY (2007)
Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A
J. Astermark et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A
Jan Astermark et al.
BLOOD (2006)
Polycomb silencers control cell fate, development and cancer
Anke Sparmann et al.
NATURE REVIEWS CANCER (2006)
Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses
Tobias Warger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Principal components analysis corrects for stratification in genome-wide association studies
Alkes L. Price et al.
NATURE GENETICS (2006)
Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A
J Astermark et al.
BLOOD (2006)
Genome-wide review of transcriptional complexity in mouse protein kinases and phosphatases
ARR Forrest et al.
GENOME BIOLOGY (2006)
Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type 1 diabetes
A Jaeschke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis
DR Hammaker et al.
JOURNAL OF IMMUNOLOGY (2004)
Positive and negative regulation of T-cell activation through kinases and phosphatases
T Mustelin et al.
BIOCHEMICAL JOURNAL (2003)
The CDM protein DOCK2 in lymphocyte migration
K Reif et al.
TRENDS IN CELL BIOLOGY (2002)
Inhibitor development in correlation to factor VIII genotypes
J Oldenburg et al.
HAEMOPHILIA (2002)
Regulation of Th2 cell differentiation by mel-18, a mammalian polycomb group gene
M Kimura et al.
IMMUNITY (2001)
Signaling by the JNK group of MAP kinases
C Dong et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2001)
The Malmo International Brother Study (MIBS): further support for genetic predisposition to inhibitor development
J Astermark et al.
HAEMOPHILIA (2001)
分享论文
